121 related articles for article (PubMed ID: 37862319)
1. Cumulative incidence of first recurrence after curative treatment of stage I-III colorectal cancer. Competing risk analyses of temporal and anatomic patterns.
Storli PE; Dille-Amdam RG; Skjærseth GH; Gran MV; Myklebust TÅ; Grønbech JE; Bringeland EA
Acta Oncol; 2023 Dec; 62(12):1822-1830. PubMed ID: 37862319
[TBL] [Abstract][Full Text] [Related]
2. Descriptive characteristics of colon and rectal cancer recurrence in a Danish population-based study.
Holmes AC; Riis AH; Erichsen R; Fedirko V; Ostenfeld EB; Vyberg M; Thorlacius-Ussing O; Lash TL
Acta Oncol; 2017 Aug; 56(8):1111-1119. PubMed ID: 28339306
[TBL] [Abstract][Full Text] [Related]
3. Recurrence and cancer-specific death after adjuvant chemotherapy for Stage III colon cancer.
Chapuis PH; Bokey E; Chan C; Keshava A; Rickard MJFX; Stewart P; Young CJ; Dent OF
Colorectal Dis; 2019 Feb; 21(2):164-173. PubMed ID: 30253025
[TBL] [Abstract][Full Text] [Related]
4. Incidence of Recurrence and Time to Recurrence in Stage I to III Colorectal Cancer: A Nationwide Danish Cohort Study.
Nors J; Iversen LH; Erichsen R; Gotschalck KA; Andersen CL
JAMA Oncol; 2024 Jan; 10(1):54-62. PubMed ID: 37971197
[TBL] [Abstract][Full Text] [Related]
5. Recurrence patterns after curative resection of colorectal cancer in patients followed for a minimum of ten years.
Sadahiro S; Suzuki T; Ishikawa K; Nakamura T; Tanaka Y; Masuda T; Mukoyama S; Yasuda S; Tajima T; Makuuchi H; Murayama C
Hepatogastroenterology; 2003; 50(53):1362-6. PubMed ID: 14571738
[TBL] [Abstract][Full Text] [Related]
6. Cumulative Incidence, Risk Factors, and Overall Survival of Disease Recurrence after Curative Resection of Stage II-III Colorectal Cancer: A Population-based Study.
Boute TC; Swartjes H; Greuter MJE; Elferink MAG; van Eekelen R; Vink GR; de Wilt JHW; Coupé VMH
Cancer Res Commun; 2024 Feb; 4(2):607-616. PubMed ID: 38363145
[TBL] [Abstract][Full Text] [Related]
7. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy for rectal cancer patients treated with preoperative (chemo)radiotherapy and total mesorectal excision: a Dutch Colorectal Cancer Group (DCCG) randomized phase III trial.
Breugom AJ; van Gijn W; Muller EW; Berglund Å; van den Broek CBM; Fokstuen T; Gelderblom H; Kapiteijn E; Leer JWH; Marijnen CAM; Martijn H; Meershoek-Klein Kranenbarg E; Nagtegaal ID; Påhlman L; Punt CJA; Putter H; Roodvoets AGH; Rutten HJT; Steup WH; Glimelius B; van de Velde CJH
Ann Oncol; 2015 Apr; 26(4):696-701. PubMed ID: 25480874
[TBL] [Abstract][Full Text] [Related]
9. Postoperative adjuvant chemotherapy with 1-hexylcarbamoyl-5-fluorouracil in patients with colorectal cancer and at a high risk for recurrence.
Maehara Y; Sugimachi K; Ogawa M; Kakegawa T; Tomita M; Akiyoshi T
Anticancer Res; 1998; 18(6B):4629-34. PubMed ID: 9891531
[TBL] [Abstract][Full Text] [Related]
10. Annual hazard rate of relapse of stage II and III colorectal cancer after primary therapy.
Mejri N; Dridi M; Labidi S; El Benna H; Daoud N; Boussen H
Clin Transl Oncol; 2017 Dec; 19(12):1524-1530. PubMed ID: 28589428
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival benefits of adjuvant chemotherapy by decreasing incidence of tumor recurrence without delaying relapse in stage III colorectal cancer.
Tsai WS; Hsieh PS; Yeh CY; Chiang JM; Tang R; Chen JS; Changchien CR; Wang JY
Int J Colorectal Dis; 2011 Oct; 26(10):1329-38. PubMed ID: 21556841
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of primary tumor location in Stage III colorectal cancer-right-sided colon versus left-sided colon versus rectum: a nationwide multicenter retrospective study.
Shida D; Inoue M; Tanabe T; Moritani K; Tsukamoto S; Yamauchi S; Sugihara K; Kanemitsu Y
J Gastroenterol; 2020 Oct; 55(10):958-968. PubMed ID: 32651860
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant Chemotherapy Does Not Improve Recurrence-Free Survival in Patients With Stage 2 or Stage 3 Rectal Cancer After Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
Voss RK; Lin JC; Roper MT; Al-Temimi MH; Ruan JH; Tseng WH; Tam M; Sherman MJ; Klaristenfeld DD; Tomassi MJ
Dis Colon Rectum; 2020 Apr; 63(4):427-440. PubMed ID: 31996583
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of surgery and adjuvant therapy in older patients with colorectal cancer: a STROBE-compliant article.
Yang L; Ma Q; Yu YY; Wang C; Meng WJ; Adell G; Albertsson M; Arbman G; Jarlsfelt I; Peng ZH; Li Y; Zhou ZG; Sun XF
Medicine (Baltimore); 2014 Dec; 93(28):e266. PubMed ID: 25526455
[TBL] [Abstract][Full Text] [Related]
15. Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer.
Tie J; Cohen JD; Wang Y; Christie M; Simons K; Lee M; Wong R; Kosmider S; Ananda S; McKendrick J; Lee B; Cho JH; Faragher I; Jones IT; Ptak J; Schaeffer MJ; Silliman N; Dobbyn L; Li L; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P
JAMA Oncol; 2019 Dec; 5(12):1710-1717. PubMed ID: 31621801
[TBL] [Abstract][Full Text] [Related]
16. The use of adjuvant chemotherapy is not associated with recurrence or cancer-specific death following curative resection for stage III rectal cancer: a competing risks analysis.
Ng KS; Chan C; Rickard MJFX; Keshava A; Stewart P; Chapuis PH
World J Surg Oncol; 2023 May; 21(1):152. PubMed ID: 37198644
[TBL] [Abstract][Full Text] [Related]
17. Disease recurrence after colorectal cancer surgery in the modern era: a population-based study.
Qaderi SM; Galjart B; Verhoef C; Slooter GD; Koopman M; Verhoeven RHA; de Wilt JHW; van Erning FN
Int J Colorectal Dis; 2021 Nov; 36(11):2399-2410. PubMed ID: 33813606
[TBL] [Abstract][Full Text] [Related]
18. A competing risk analysis of colorectal cancer recurrence after curative surgery.
Schellenberg AE; Moravan V; Christian F
BMC Gastroenterol; 2022 Mar; 22(1):95. PubMed ID: 35241002
[TBL] [Abstract][Full Text] [Related]
19. Long-term results of 2 adjuvant trials reveal differences in chemosensitivity and the pattern of metastases between colon cancer and rectal cancer.
Kornmann M; Staib L; Wiegel T; Kron M; Henne-Bruns D; Link KH; Formentini A;
Clin Colorectal Cancer; 2013 Mar; 12(1):54-61. PubMed ID: 23107590
[TBL] [Abstract][Full Text] [Related]
20. Gene-expression signature of tumor recurrence in patients with stage II and III colon cancer treated with 5'fluoruracil-based adjuvant chemotherapy.
Giráldez MD; Lozano JJ; Cuatrecasas M; Alonso-Espinaco V; Maurel J; Mármol M; Hörndler C; Ortego J; Alonso V; Escudero P; Ramírez G; Petry C; Lasalvia L; Bohmann K; Wirtz R; Mira A; Castells A
Int J Cancer; 2013 Mar; 132(5):1090-7. PubMed ID: 22833293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
